Ownership as of September 30, 2020. Twenty largest shareholders.
NameSeries A sharesSeries B sharesShare capital %Voting rights %
ANNWALL & ROTHSCHILD INVESTMENTS AB377 736410 4787,0228,63
ÖHMAN BANK S.A.-1 174 01710,468,03
FJÄRDE AP FONDEN-1 112 9199,917,61
SWEDBANK ROBUR NY TEKNIK BTI-579 1725,163,96
AMF AKTIEFOND SMÅBOLAG-501 5854,473,43
TREDJE AP-FONDEN-488 5654,353,34
UNIONEN-447 1963,983,06
HANDELSBANKEN SVENSKA, SMABOLAGSFOND-370 0003,302,53
CBNY-NORGES BANK-353 2202,922,24
DANGOOR, DAVID-281 2602,521,94
RBC INVESTOR SERVICES BANK S.A-263 9542,351,80
ANDRA AP-FONDEN-263 5002,351,80
ÅLANDSBANKEN I ÄGARES STÄLLE-239 9192,141,64
HANDELSBANKEN MICROCAP SVERIGE-238 4612,121,63
BANQUE PICTET & CIE SA, W8IMY (WITHOUT P.R.-235 3802,101,61
LÄNSFÖRSÄKRINGAR SMÅBOLAG SVERIGE-195 7091,741,34
FÖRSÄKRINGSAKTIEBOLAGET, AVANZA PENSION-185 3611,651,27
NORDNET PENSIONSF÷RSƒKRING AB-143 2281,280,98
HANVAD INVEST AKTIEBOLAG-136 5931,220,93
SEB AB, LUXEMBOURG BRANCH, W8IMY-120 5821,070,82
Sub-total377 7367 741 09972,1178,59
Other shareholders-3 107 34927,8921,41
Total377 73610 848 448100100
Source: Euroclear Sweden AB
The total registered share capital of Infant Bacterial Therapeutics AB consists of 377,736 class A shares with 10 votes per share and 10,848,448 class B shares with one vote per share, in total 11,226,184 shares.